Shay Shemesh - 10 May 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Shay Shemesh
Issuer symbol
NVCT
Transactions as of
10 May 2024
Net transactions value
+$7,034
Form type
4
Filing time
13 May 2024, 08:47:51 UTC
Previous filing
05 Jan 2024
Next filing
03 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $7,034 +1,113 +0.07% $6.32 1,493,068 10 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.19 to $6.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
F2 Includes 353,399 shares of restricted stock.